The immune cell landscape in kidneys of lupus nephritis patients
Arnon Arazi 1, 21 , Deepak A. Rao 2, 21 , Celine C. Berthier 3, 21 Immune-mediated injury of the kidney, referred to as lupus nephritis (LN), is a frequent complication of systemic lupus erythematosus (SLE) 1, 2 . Current immunosuppressive therapies for LN are both toxic and insufficiently effective, and a substantial number of patients progress to end stage renal disease and death 2, 3 . Despite the rapid pace of immunologic discovery, most clinical trials of rationally designed therapies have failed in both general SLE and LN, and only one new drug has been approved for the treatment of SLE in the last 5 decades 2, 4 . Thus, there is a pressing need to decipher the immune mechanisms that drive target organ damage in LN.
To meet this goal, we set out to identify the types and activation states of immune cells in the kidneys of LN patients, as part of the NIH Accelerating Medicines Partnership (AMP) RA/SLE consortium, with the eventual goal of collecting and analyzing immune responses in hundreds of patients. Here, we report the development of a standardized protocol to process kidney samples acquired across a distributed clinical and research network, and to analyze them using singlecell transcriptomics. We applied this pipeline to study a proof-of-concept cohort composed of LN patients and healthy living allograft donors (LD). Our analysis delineates, for the first time, the complex network of leukocytes active in LN kidneys. In addition, we analyzed gene expression in single cells isolated from urine samples of LN patients, showing that these have the potential to be used as surrogates for kidney biopsies in assessing the molecular activation state of renal immune cells.
RESULTS

Isolation and processing of LN and LD kidney cells for single-cell transcriptomics
In order to establish a uniform pipeline to analyze kidney biopsy samples acquired at multiple institutions, we evaluated several strategies for their preservation and transport.
Cryopreservation of intact, viable kidney tissue offered a method to preserve samples rapidly after acquisition, transport samples with flexible scheduling, and perform sample processing at a central site. We evaluated the feasibility of this method using kidney tissue obtained from tumor nephrectomy samples and then validated the developed workflow using LN and LD biopsies.
Kidney tissue samples cryopreserved in a 10% DMSO-containing solution provided robust leukocyte yields, with ~50% reduction compared to freshly dissociated tissue ( Supplementary   Fig. 1a ). Cryopreserved intact kidney samples yielded higher leukocyte counts than samples that were cryopreserved after tissue dissociation, and comparable leukocyte yields and frequencies to samples shipped overnight in a saline solution on wet ice ( Supplementary Fig.   1b ,c). Leukocytes from cryopreserved kidney tissue samples showed intact staining for lineage markers by flow cytometry and yielded bulk RNA-seq transcriptomes of equivalent quality to those from non-frozen samples ( Supplementary Fig. 1d ,e). These results demonstrate that high quality flow cytometric and transcriptomic data can be obtained from leukocytes derived from cryopreserved kidney tissue.
We implemented this pipeline of viable tissue cryopreservation, followed by batched Viable cells were sorted into 384-well plates, and single-cell RNA-seq (scRNA-seq) was performed using a modified version of the CEL-Seq2 protocol, followed by sequencing of ~1 million paired-end reads per cell. Since our focus was on characterizing the immune cells active in LN kidneys, 90% of the cells sequenced from each sample were CD45 + cells, and the rest were CD45 -CD10 + cells. To exclude low-quality cells and doublets, we filtered out cells that had less than 1,000 or more than 5,000 detected genes, or in which the percentage of mitochondrial genes was larger than 25%. The quality of the collected sequencing data was comparable across plates, and higher in leukocytes compared to epithelial cells, reflecting the lower viability of the latter in the processed samples ( Supplementary Fig. 1f-g ). Principal component analysis performed on the gene expression data from the remaining 2,736 leukocytes and 145 epithelial cells indicated that the main sources of variability in the data corresponded to cell types, rather than batch or technical factors ( Supplementary Fig. 2e -f).
Step-wise cell clustering identifies cells of the myeloid, T, NK, B and epithelial lineages
In order to identify the lineage of the cells extracted from kidney samples and to characterize their activation state, we clustered them based on their gene expression data, taking a stepwise approach (Fig. 1b) . Starting with low-resolution clustering of all kidney cells, we identified 10 clusters ( Supplementary Fig. 2g ), which we labeled as myeloid cells (clusters C4 and C6), the exception of two (described below), were either absent or present at negligible frequency in LD control samples (Fig. 2b) .
Type I interferons have long been known to be elevated in the peripheral blood of lupus Table 3 ). The fact that these two patients also featured B cells and CD4 + T cells with a substantially less prominent interferon response suggests that the secretion of this cytokine may be spatially localized to distinct niches, at least in some patients.
Classification and annotation of myeloid cell clusters reveal resident and infiltrating populations
Focused analysis of the 466 cells in myeloid clusters C4 and C6 revealed 5 finer clusters (clusters CM0-CM4, Fig. 3a ; Supplementary Fig. 3a-c) . We determined the putative identity of the cells in these clusters by comparing their global gene expression patterns to those of published reference monocyte/dendritic cell (DC) clusters identified in blood samples of healthy individuals using scRNA-seq 6 ( Fig. 3b,c ; Supplementary Fig. 3d ), and by the expression of canonical lineage markers. Cluster CM3 was closest to CD1c + DCs (reference clusters DC2 and DC3) or Clec9a + DCs (reference cluster DC1), in accordance with the expression of the canonical DC markers CD1C and FLT3, as well as the lack of expression of monocyte markers CD14 and CD16. Cluster CM0 cells were most similar to CD16 + patrolling monocytes (reference clusters Mono2 and DC4) with very high expression of CD16 (FCGR3A) and CX3CR1 and low expression of CD14 and CCR2. Clusters CM1 and CM4 were also most similar to reference cluster Mono2; however, CM1 cells expressed lower levels of CX3CR1 and CD16 than CM0, while CM4 cells expressed even lower levels of these two genes and in contrast higher levels of CD14 and CD64 (FCGR1A). These 3 clusters likely represent infiltrating kidney monocyte/macrophage subsets as they constitute a small minority of myeloid cells in normal kidney (Fig. 2b) .
We next determined whether the pattern of gene expression in each cluster could indicate functional capabilities such as phagocytosis and inflammation, which represent major macrophage activities in damaged tissues 7, 8, 9 ( Supplementary Fig. 3a ). Cluster CM1 expressed upregulated levels of phagocytic receptors CD36 (SCARB3), SCARB2, CD68, CD163, NR1H3
(LXR), and GPNMB and cluster CM4 expressed VSIG4, MSR1, CD163, MERTK, STAB1 and CD209. Cells in CM1 and especially CM4 had upregulated expression of C1Q, which not only acts as an opsonin for phagocytosis but also promotes apoptotic cell clearance by enhancing the expression of MERTK (in the presence of other molecules, such as HMGB1) and its soluble ligand GAS6 10, 11 . Clusters CM1 and CM4 also expressed the highest levels of the sialic acid binding immunoglobulin lectin CD169 (SIGLEC1), an endocytic receptor that has been detected on infiltrating macrophages in a variety of human renal inflammatory diseases and that is associated with a phagocytic and reparative phenotype 12 . Cluster CM0 had the highest level of expression of inflammatory genes including TNF, S100A8, S100A9, NFKB1 and the Wnt pathway activator TCF7L2. By contrast, CM4 expressed many genes associated with alternatively activated macrophages, including CD163 and SLC40A1 (ferroportin), which control iron homeostasis 13 . CM4 also abundantly expressed IGF1 and DAB2, both drivers of the alternatively activated phenotype 14, 15 and folate receptor beta (FOLR2), a receptor expressed on alternatively activated CD14 + macrophages that are found in multiple inflammatory and malignant tissues 16 .
Finally, since CM2 was the main cluster found in normal kidneys (Fig. 2b) , it likely corresponds to steady-state kidney macrophages. This cluster demonstrated low expression of CD14, CD16, CX3CR1 and CCR2, and no clear similarity to the published reference clusters of peripheral myeloid subsets (Fig. 3b) . In comparison to the other macrophage subsets in the kidney, CM2 (Fig. 3c) , the suggested progression is from an inflammatory blood monocyte (CM0) to a phagocytic (CM1) and then an alternatively activated (CM4) phenotype. As examples of genes reflecting such a progression, we found a gradual reduction along the trajectory from CM0 to CM4 in the expression of NFKB1, an inflammatory gene (Fig. 3e) ; a transient increase in CD36, an important phagocytic receptor (Fig. 3f) ; and a continuous increase in MERTK, a key signaling receptor induced by CD36 (Fig. 3g) 
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. We note, however, that other schemes of transitions (or their absence) between these clusters are possible, and further investigation is required to decide between them. and XCL1 and lack of KLF2 24, 25 . In line with this proposed identity, CT5a was the most abundant CD8 + T cell cluster in normal kidney biopsies ( A closer look at the tSNE plot for the B cells suggested that cluster CB2 may contain multiple subsets ( Supplementary Fig. 5b ). Furthermore, some of the markers distinct to this cluster, such as CD4, PTPRS and GZMB are not known to be expressed in B cells. On further analysis we were able to split the cells in cluster CB2 into two subclusters ( Fig. 5c; Supplementary Fig. 5c ):
the first of these (CB2a), expressing the B cell markers CD19 and CD20 (MS4A1), demonstrated upregulation of genes typical of naïve B cells, including high levels of IGHD, IGHM, TCL1A and IL4R, and had nearly undetectable expression of CD27; the other cluster (CB2b) expressed genes known to be upregulated in pDCs ( Fig. 5c; Supplementary Fig. 5c ), including PTPRS, GZMB, CLEC4C, CD123 (IL3RA) and CD317 (BST2). To further validate this hypothesized identification, we calculated the Pearson correlation in gene expression between each cell in cluster CB2 and three independent sets of reference samples. These sets included 
Indirect evidence for B cell activation and differentiation into age-associated B cells in the kidney
We next asked whether B cell activation and differentiation may take place in the inflamed kidney. Our sequencing data, which is composed of short, 3' end fragments, is not suitable for a direct analysis of BCR repertoires and their distribution across the B cell clusters. We therefore approached this question looking at indirect evidence, and in particular the existence of intermediate states between the identified B cell subsets. Projecting the gene expression data of the B cells onto 2 dimensions using diffusion maps 18 , we found that the naïve (CB2a) and activated (CB0) B cells formed a continuum of states, demonstrating a gradual increase in CD27 expression and a parallel decrease in IGHD expression, consistent with local activation (Fig. 5d-f) . Furthermore, traversing the trajectory from CB2a to CB0 coincided with a continuous increase in the ABC score (Fig. 5g) However, as it was previously suggested that age-associated B cells are pre-plasma cells, this question requires a more direct investigation, in particular employing BCR repertoire analysis.
The dividing cells cluster includes T and NK cells
A focused analysis of cluster C9 found that it can be further partitioned into 3 finer clusters ( Supplementary Fig. 6a ). The cells in two of these clusters (CD1, CD2) expressed mitochondrial genes and genes associated with a stress response ( Supplementary Fig. 6b ), indicating lower viability and/or quality. We therefore excluded these cells from subsequent analyses. Fig. 6c ).
Cluster-specific expression of genes associated with disease risk
Genome-wide association studies (GWAS) have identified numerous risk alleles and their susceptibility genes in SLE and LN 32, 33 . We analyzed the expression of these genes across the 22 clusters identified in kidneys, and found both expected and surprising cluster-specific expression patterns (Fig. 6a) We further analyzed the change of some of these genes along the putative trajectory from cluster CM0 to cluster CM4 (Fig. 3d, Fig. 6b-g ). We found that CSK and LYN, which regulate the Src family kinase response to weak signals and act as a rheostat for inflammatory signaling 39 are downregulated along this trajectory, making the macrophages less inflammatory as they transition. A concurrent upregulation of CIITA and HLA-DQA1 suggests an increasing role in antigen presentation. Finally, since it is known that CD44 is required for macrophage infiltration into other organs, the upregulation of ITGAM and downregulation of CD44 raises the hypothesis that these cells become less motile and more adhesive as they transition into the interstitium of the kidney.
Cellular networks mediated by chemokines and cytokines
To identify signals modulating the activity of leukocytes infiltrating the kidney, we analyzed the expression patterns of chemokine and cytokine receptors. We focused on receptors that were expressed by a relatively large fraction (> 30%) of the cells in at least one cluster (this threshold was set based on the observed distribution of expression frequency, considering all receptors; Supplementary Fig. 7a ). Most receptors demonstrated cell type-specific expression patterns (Fig. 7a) . However, we found that a single chemokine receptor, CXCR4, was expressed in the majority of infiltrating cells in nearly all clusters (Supplementary Fig. 7b) . A second chemokine receptor, CX3CR1, was expressed in most myeloid cells, as well as CD56 dim CD16 + NK cells (cluster CT1) and CTLs (CT2) (Supplementary Fig. 7c ). Of note, the expression frequency of other chemokine receptors previously implicated in LN, such as CCR5, CXCR3 and CCR2, was found to be much lower ( Supplementary Fig. 7d-f) . For cytokine receptors, we observed that IL2RG, encoding the common gamma chain and important for signaling of several cytokines, was frequently expressed in almost all clusters. TGFBR2, a subunit of the receptor for TGFβ was also expressed on the majority of cells. IL10RA, IL27RA, IL17RA and TNFRSF1B were expressed by a large fraction of cells in all clusters, with the exception of the B cells.
By analyzing the expression patterns of the corresponding ligands, one may hope to identify putative interactions between the cells acting in the inflamed kidney. We found that the CXCR4 ligand, CXCL12, was expressed mainly in the cells in cluster CM4, as well as in the epithelial cells (Fig. 7b, Supplementary Fig. 7g ). The latter were also the main source of the CX3CR1 ligand, CX3CL1 ( Fig. 7c; Supplementary Fig. 7h ). Interestingly, CM4 cells were in addition the top producers of CCL2 and CCL8 ( Supplementary Fig. 7i ), the ligands of CCR2, which is expressed in a high fraction of plasma cells (cluster CB1) and pDCs (cluster CB2b). These findings indicate a possible central role played by the kidney epithelial cells and the M2-like macrophages in cluster CM4 in coordinating the traffic of immune cells infiltrating the kidney.
Comparison of urine and kidney leukocytes
Leukocytes isolated from urine samples of LN patients were processed in the same way as kidney cells (Fig. 1a) . Urine leukocytes tended to have fewer detectable genes, compared to kidney leukocytes ( Supplementary Fig. 1h ). We therefore applied lower thresholds onto the number of genes detected when discarding low-quality urine cells. Following filtering, 577 highquality cells, collected from 8 patients, were included in subsequent analyses. Only 3 patients had matching kidney and urine samples with substantial cell numbers; we therefore focused on comparing urine and kidney cells across all patients taken together, rather than performing a patient-based analysis.
We first assigned each urine cell to a cluster of kidney cells, choosing the cluster to which it was most correlated in its gene expression data. We found that compared to kidney, urine samples had an overrepresentation of myeloid cells (in particular cluster CM1) and fewer T cells (Fig.   8a ). We next compared gene expression across corresponding urine and kidney clusters, restricting the comparison to clusters that had more than 5 urine cells. High correlations were observed, typically ranging from 0.85 to 0.95 (Fig. 8b ). This suggests that gene expression measurements in urine clusters can serve as estimates of kidney gene expression in corresponding clusters; in particular, such estimates were found to be more accurate for genes demonstrating a medium or high expression level ( Supplementary Fig. 8a-b) .
DISCUSSION
The advent of single cell transcriptomics has enabled analysis of cells from patient samples in unprecedented detail. Here, we used this approach to study, for the first time, kidney samples obtained from LN patients and LD controls. Our analysis revealed the complexity of the immune populations acting in LN kidneys, and showed that these contain several subsets of myeloid, NK, T and B cells, most of which are not found in the kidneys of LD controls. We consider this a first draft map of the immune cell types and states in LN and LD kidneys; sampling of more patients and cells will be required to determine its degree of completeness. . Further changes are induced in cells that phagocytose dead material 54 . In line with this, we identified a putative resident population of renal macrophages that have an interferon signature but also express a number of anti-inflammatory genes.
During tissue injury, monocytes can enter tissues from the peripheral blood and can further differentiate into inflammatory macrophages and reparative/resolving macrophages in situ 55, 56, 57 . If the cells are chronically exposed to damage-associated molecular pattern molecules (DAMPs) and endosomal TLR ligands, resolution may fail, and macrophages with mixed functions may emerge 58 . We identified three distinct sub-populations of infiltrating macrophages, all with a gene expression pattern that most resembled that of peripheral CD16 + /CD14 dim monocytes. These "patrolling" cells function to monitor the integrity of endothelial cells 59 but can be activated through TLR7 and TLR8 to produce inflammatory cytokines via sensing of nucleic acids produced by damaged cells 60 . Glomerular CD68 + macrophages have been reported in many histologic studies of LN, suggesting patrolling behavior, and are associated with more severe clinical disease in a subset of LN patients 60, 61 . Our study suggests that the three subpopulations of CD16 + related macrophages identified here may transition through an inflammatory to a resolution phase. Interestingly, CD209 (DC-SIGN), a marker limited to CM4, is known to be expressed predominantly by interstitial macrophages in LN biopsies 62 , showing that this subset has infiltrated the tissue. Expression of CD163, which marks an alternatively activated macrophage phenotype that is highly represented in LN kidneys 63 , was less useful here in distinguishing the macrophage subsets.
DCs may also enter injured kidneys from the peripheral blood, have a short half-life and are most often located within interstitial lymphoid infiltrates 64 . We confirmed that pDCs, myeloid DCs and CLEC9A + DCs are all present in the kidneys of LN patients. Renal infiltration of these classic DC cell types is associated with the later stages of renal injury and fibrosis in human glomerular diseases 64 .
A prominent feature of the gene expression pattern of most of the identified cell types is the expression of IFN inducible genes. While all cells showed this signature to some extent, it was more prominent in some cell types than in others, including subsets of B cells and CD4 T, and varied both between and within patients suggesting that there is spatial heterogeneity with respect to the microenvironment in which this activation occurs.
Our analysis of urine samples showed that while the relative cluster frequencies in the kidney are not accurately reflected in urine, gene expression is highly correlated in these two compartments. This suggests that urine samples can be used to monitor changes over time in the molecular pathways activated in the kidney, in the course of disease and in response to treatment.
Overall, the work presented here demonstrates the feasibility of profiling kidney samples using single cell transcriptomics. Furthermore, our novel strategy to cryopreserve viable kidney tissue immediately after acquisition allowed us to study samples collected at multiple sites, while 
METHODS
Human kidney tissue and urine acquisition
Renal tissue and urine specimens from LN patients were acquired at 10 clinical sites in the United States. Institutional review board approval was received at each site. Research biopsy cores were collected from consented subjects either as an additional biopsy pass obtained specifically for research during a clinically-indicated biopsy procedure (9 sites), or as a portion of a biopsy specimen acquired for diagnostic pathology during a clinically-indicated biopsy procedure (1 site). Control kidney samples were obtained at a single site by biopsy of a living donor kidney after removal from the donor and prior to implantation in the recipient.
After acquisition, kidney biopsy samples were placed into HypoThermosol FRS preservation solution for 10-30 minutes on ice and then transferred to a cryovial containing 1 ml of CryoStor CS10 cryopreservation medium (BioLife Solutions). The cryovial was incubated on ice for 20-30 min and was then placed in a Mr. Frosty freezing container (Nalgene, #5100-0001) and transferred to a -80°C freezer overnight. Cryopreserved samples were then stored in liquid nitrogen and shipped on dry ice to the central processing site, where they were stored in liquid nitrogen until processing.
Kidney tissue thawing and dissociation into a single cell suspension
Kidney samples were thawed and processed in batches of 4 samples, with most batches containing both LN and control kidney samples. The cryovial containing the kidney tissue was rapidly warmed in a 37C water bath until almost thawed. The sample was then poured into a well of a 24-well dish and rinsed in a second well containing warmed RPMI/10%FBS. The tissue was incubated for 10 minutes at room temperature. Specimens were cut into 2-3 pieces and placed into a 1.5 ml centrifuge tube containing 445uL of Advanced DMEM/F-12 (ThermoFisher Scientific, #12634-028) and 5uL of DNase I (Roche, #04536282001, 100U/ml final concentration). 50uL of Liberase TL (Roche, #05401020001, 250ug/mL final concentration) was added, and the tube was placed on an orbital shaker (300-500 rpm) at 37°C for 12 minutes. At 6 minutes into the digestion, the mixture was gently pipetted up and down several times using a cut 1 mL pipette tip. After 12 minutes, 500uL of RPMI/10% FBS was added to stop the digestion. The resulting cell suspension was filtered through a 70-µm filter into a new 1. 
Library preparation and RNA sequencing
Single cell RNAseq (scRNA-Seq) was performed using the CEL-Seq2 method 65 with the following modifications. Single cells were sorted into 384-well plates containing 0.6µL 1% NP-40 buffer in each well. Then, 0.6µL dNTPs (10mM each; NEB) and 5nl of barcoded reverse transcription primer (1µg/µL) were added to each well along with 20nL of ERCC spike-in (diluted 1:800,000). Reactions were incubated at 65°C for 5min, and then moved immediately to ice. Reverse transcription reactions were carried out and as previously described 65 and cDNA was purified using 0.8X volumes of AMPure XP beads (Beckman Coulter). In vitro transcription reactions (IVT) were performed as described followed by EXO-SAP treatment. Amplified RNA (aRNA) was fragmented at 80°C for 3min and purified using RNAClean XP beads (Beckman Coulter). The purified aRNA was converted to cDNA using an anchored random primer and Illumina adaptor sequences were added by PCR. The final cDNA library was purified using AMPure XP beads (Beckman Coulter). Paired-end sequencing was performed on the HiSeq 2500 in Rapid Run Mode with a 5% PhiX spike-in using 15 bases for Read1, 6 bases for the Illumina barcode and 36 bases for Read2.
RNA-seq Data Processing
We used a modified version of the Drop-seq pipeline developed by the McCarroll lab (http://mccarrolllab.com/wp-content/uploads/2016/03/DropseqAlignmentCookbookv1.2Jan2016.pdf) adapted for CEL-Seq2, to perform all steps necessary to produce gene by cell expression matrices of reads as well as UMIs. These steps include demultiplexing, quality filtering, polyA and adapter trimming, aligning, and collapsing reads with unique combinations of cell+gene+UMI. We used STAR-2.5.1b to align reads to the Hg19 human genome reference. Only uniquely mapped reads were counted. UMIs with fewer than 10 reads were filtered out before creating the final expression matrices, to minimize reads crosscontamination across cells. For each cell, the computed gene expression counts were then normalized for read depth and log transformed.
Cell Filtering and Quality Control
High quality cells were defined as having at least 1,000 detected genes (i.e. with positive count values). We further required the percentage of mitochondrial genes per cell to be lower than 25%. To remove wells that were suspected to contain mRNA from multiple cells, we required the number of genes per cell to be smaller than 5,000.
To minimize the effect of technical factors, we tested different regression models, taking into account such variables as the plate ID, number of UMIs per cell, and the percentage of mitochondrial genes per cell. We found that using such models had a negligible effect on the gene by cell expression matrix, as well as the overall results of clustering. We therefore decided to avoid employing them in cleaning the data for subsequent analyses.
Cell Clustering
Clustering of cells was done using Seurat (v1.4.0.8)
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, in a step-wise manner. We initially clusters. In some cases, as described in the main text, the resulting clusters further split into subclusters. In each case, clustering was done following PCA, based on context-specific variable genes that were identified independently for each set of analyzed cells.
Sensitivity analysis was performed in each clustering step, with a particular focus on the lowresolution clustering stage. Briefly, all parameters in the clustering process, including the number of variable genes and principal components considered, were varied, and the robustness of the results was determined. To assess this robustness, we computed in each case a consistency score, based on a reference clustering run: looking at a large number
(1,000) of random pairs of cells, we counted how many pairs were either included in the same cluster in both of the compared clustering runs, or not included in the same cluster, and referred to these as consistent pairs; we then calculated the fraction of consistent pairs out of all random cell pairs considered. We repeated this procedure 100 times, to calculate the mean consistency score.
Classification by correlation
In 
Differential expression analysis
Identification of genes differentially expressed between LN patients and LD controls was done using the framework proposed by McDavid et al. 67 , as implemented by Seurat. P-values were corrected for multiple comparisons using the Benjamini-Hochberg method 68 . DE analysis was performed separately for each cluster with at least 10 cells in both patient groups.
Trajectory analysis
Trajectory analysis was performed based on dimensionality reduction using diffusion maps, as implemented in the Destiny software package (v2.6.2) 18 . In each case, only the cells relevant to the question at hand were analyzed.
Calculation of an age-associated B cell score (ABC score)
For each cell in cluster CB0, we defined the ABC score as the average of the scaled (Znormalized) expression of the genes known to be upregulated in age-associated B cells, minus the average of the scaled expression of the genes known to be downregulated in these cells (see the main text for the lists of upregulated and downregulated genes).
Analysis of GWAS genes expression
We analyzed the expression patterns of 180 genes previously reported in GWAS studies of either SLE or lupus nephritis. For each such gene, we calculated its average scaled (Znormalized) expression in each cell cluster, taking into account only cells coming from LN samples. For Bi-clustering of GWAS genes and cell clusters, we kept only genes that had an average scaled expression value of more than 1 or less than -1 in at least one cell cluster, such that bi-clustering was based only on the GWAS genes that were relatively variable in our data.
Bi-clustering was then performed, based on the average scaled expression in each cell cluster and using a Euclidean distance metric.
Analysis of chemokine/cytokine receptors
Analysis of chemokine/cytokine receptors was based on a receptor-ligand pairs list downloaded from the IUPHAR/BPS database (http://www.guidetopharmacology.org/download.jsp) and extended manually to incorporate a number of missing, previously published pairs. For each receptor, we calculated the percentage of cells expressing it in each cell cluster, where a receptor was said to be expressed by a cell if it had at least one mapped read (the results reported here were found to be robust to changes in this threshold). For bi-clustering of receptors and cell clusters, we kept only receptors that appeared in at least 30% of the cells in at least one cluster.
Assignment of urine cells to kidney clusters
For each urine cell, we computed its Pearson correlation with each kidney cluster, taking the average over the kidney cells included in the cluster. The urine cell was then assigned to the cluster that produced the highest correlation value.
Code availability
All R scripts used to analyze the data reported in this publication are available from the corresponding authors upon request.
Data availability
The data reported in this publication are deposited in the ImmPort repository and accessible with accession code SDY997. show the distribution of expression levels in equally-spaced intervals along the pseudotime axis (and do not directly correspond to cell clusters). 
